{
    "code": "01036187",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01036187",
    "time": "2023-04-21 06:04:45",
    "許可證字號": "衛署藥製字第036187號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "117\/03\/03",
    "發證日期": "82\/03\/03",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHY00103618701",
    "中文品名": "&quot;華盛頓&quot; 甘草流浸膏",
    "英文品名": "EXTRACTUM GLYCYRRHIZAE LIQUIDUM &quot;W.P&quot;",
    "適應症": "止咳、袪痰。",
    "劑型": "177流浸膏劑",
    "包裝": "60-4000公撮、5加侖塑膠瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "04調劑專用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "GLYCYRRHIZA POWDER",
    "限制項目": "01國　產 1R不得製造",
    "申請商名稱": "1202801200  華盛頓製藥廠股份有限公司",
    "申請商地址": "高雄市仁武區仁武里工業二路12號",
    "主製造廠": [
        {
            "製造廠名稱": "1202822300  華盛頓製藥廠股份有限公司",
            "製造廠廠址": "高雄市仁武區仁武里工業二路12號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "30039099905 其他醫藥製劑（不包括第３００２、３００５或３００６節所列者），包含兩種或以上之成分業經混合供治療或預防疾病之用，不具有劑量或零售包裝式樣者Other medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200004402",
            "成分名稱": "GLYCYRRHIZA POWDER",
            "含量描述": "1",
            "含量": "1.0000000000",
            "單位": "GM"
        }
    ],
    "仿單外盒": [
        {
            "title": "甘草流浸膏-104-12-29(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01036187&Seq=001&Type=9"
        }
    ]
}